Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple MyelomaJin Jie, Hong Ma, Siguo Hao et al.|Blood|2019Cited by 40
Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple MyelomaSiguo Hao, Hong Ma, Wenhao Zhang et al.|Blood|2020Cited by 36
Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning RegimenLan Sun, Jianhua Feng, Na Wang et al.|Transplantation and Cellular Therapy|2019Cited by 27
NVP-BEZ235-induced autophagy as a potential therapeutic approach for multiple myeloma.Yongyong Ma, Qifa Liu, Zhouxiang Jin et al.|PubMed|2019Cited by 24
The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcriptionZhouxiang Jin, Yongyong Ma, Shujuan Zhou et al.|Biomedicine & Pharmacotherapy|2019Cited by 22